{"schema_version":"secwatch.filing_event.v1","accession":"0001628280-24-008496","form_type":"8-K","ticker":"ARQT","cik":"0001787306","company_name":"Arcutis Biotherapeutics, Inc.","filed_at":"2024-03-04T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.535278+00:00","generated_at":"2026-06-05T04:50:24.594565+00:00","sec_items":["9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Arcutis raises ~$161.6M in public offering of 18.2M shares at $9.50","bullets":["Issued ~18.2M shares at $9.50 via underwritten public offering, raising ~$161.6M net.","Underwriters fully exercised 30-day option to purchase additional 2,368,421 shares on Feb 29, 2024.","Net proceeds intended to fund commercialization, development, and approval for atopic dermatitis, scalp psoriasis, and psoriasis expansion.","Offering conducted under existing Form S-3 shelf registration (File No. 333-276794)."],"urls":{"canonical":"https://secwatch.observer/filing/0001628280-24-008496","json":"https://secwatch.observer/filing/0001628280-24-008496.json","markdown":"https://secwatch.observer/filing/0001628280-24-008496.md","text":"https://secwatch.observer/filing/0001628280-24-008496.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/0001628280-24-008496-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1787306/000162828024008496/arqt-20240228.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T04:50:24.594565+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}